The Wegovy Pill is a once-daily tablet form of semaglutide — the same active ingredient as the Wegovy injection — licensed for weight management. It's the answer to one of the most-asked questions in weight-loss medicine: "is there a pill version?" For people who want the effectiveness of a GLP-1 medicine without weekly injections, oral semaglutide is now a genuine option.
What is the Wegovy Pill?
It's semaglutide in tablet form. Semaglutide is a GLP-1 receptor agonist: it mimics a natural gut hormone that reduces appetite, slows how quickly food leaves the stomach and helps regulate blood sugar. The injectable version has been available for weight management in the UK for several years; the oral version delivers the same active ingredient through a once-daily tablet instead of a once-weekly injection.
Because semaglutide is a peptide that stomach acid would normally destroy, the tablet uses an absorption enhancer (SNAC) that lets the medicine be absorbed through the stomach lining. That chemistry is also why the taking-instructions matter more than for most tablets.
How do you take it?
The routine is specific, and following it makes the difference between the medicine working well and barely being absorbed:
- Take it first thing in the morning, on an empty stomach
- Swallow whole with a small sip of water only (up to about half a glass)
- Wait at least 30 minutes before eating, drinking anything else, or taking other oral medicines
Like the injection, treatment starts at a low dose and steps up gradually over several months, allowing your body to adjust and keeping side effects manageable. Your prescriber sets the schedule and reviews each increase.
Does the pill work as well as the injection?
Trial data for high-dose oral semaglutide shows weight loss in a broadly similar range to the injectable. In the OASIS programme of clinical trials, adults with overweight or obesity taking daily oral semaglutide alongside lifestyle changes lost significantly more weight than placebo, with average reductions in the low-to-mid teens as a percentage of body weight over 64–72 weeks — comparable territory to injectable semaglutide's results in STEP 1. Head-to-head, dose-for-dose comparisons are limited, and individual response always varies, but the honest summary is: the pill is in the same league as the injection, provided it's taken correctly.
Pill vs injection: how to think about the choice
| Wegovy Pill | Wegovy injection | |
|---|---|---|
| Frequency | Once daily | Once weekly |
| Routine | Empty stomach, small sip of water, 30-minute wait | Any time of day, with or without food |
| Needles | None | Very fine needle, self-injected |
| Storage | Room temperature | Refrigerated before first use |
| Travel | Simple — it's a tablet | Needs cool storage planning |
| Forgetting doses | Daily habit — easier to miss occasionally | Weekly — fewer chances to forget |
The pill tends to suit people with needle anxiety, frequent travellers, and anyone who prefers a daily routine. The injection suits people who'd rather think about treatment once a week and find a daily fasting-window routine unrealistic. Neither is clinically "better" — adherence is what drives results, so the right form is the one you'll actually take consistently.
Side effects
Because the active ingredient is the same, side effects mirror the injection: nausea, constipation or diarrhoea, bloating and reduced appetite are most common, typically mild-to-moderate, most noticeable when starting and after dose increases, and settling as the body adjusts. Taking the tablet exactly as directed also helps — erratic absorption from incorrect taking can mean erratic effects. As with all GLP-1 medicines, it isn't suitable for everyone; a clinical assessment covers personal and family medical history before any prescription.
Can I switch from injections to the pill?
Yes, with prescriber approval — this is one of the most common questions we get from existing Mounjaro and Wegovy patients. Because doses aren't directly interchangeable between forms (and not at all between tirzepatide and semaglutide), switching involves a prescriber-led transition rather than a straight swap. We've written a dedicated guide: switching from injections to the Wegovy Pill.
The bottom line
Oral semaglutide removes the biggest barrier that's kept some people away from GLP-1 treatment. It demands a stricter daily routine in exchange for no needles — and taken correctly, it delivers results in the same range as the injection. If you've been waiting for the pill, it's here; whether it's right for you is a conversation with a prescriber.
Frequently asked questions
Is there a pill version of Wegovy in the UK?
Yes. Oral semaglutide — the Wegovy Pill — is a once-daily tablet containing the same active ingredient as the Wegovy injection, available via prescription after a clinical assessment.
Is there a Mounjaro pill?
No. Mounjaro (tirzepatide) is currently injection-only. The available weight-management tablet is oral semaglutide. An oral tirzepatide-class medicine (orforglipron) is in development but not yet licensed.
Why do I have to take it on an empty stomach?
Semaglutide is a peptide that food and liquids interfere with during absorption. The empty stomach, small-sip and 30-minute rules exist so enough medicine actually reaches your bloodstream.
Is the Wegovy Pill as effective as the injection?
Trial results for oral semaglutide sit in a broadly similar range to the injectable form. Taken correctly and consistently, it's a comparably effective option; taken incorrectly, absorption — and results — suffer.
References
- Knop FK, et al. Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1). Lancet. 2023;402(10403):705–719.
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002.
- Buckley ST, et al. Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist (SNAC co-formulation). Sci Transl Med. 2018.
- Oral semaglutide — Summary of Product Characteristics. medicines.org.uk.